Journal Journal: Drug patents threatening cheap drugs
This was a story I tried to submit but was rejected by Slashdot's editorial staff. Not grousing, saving my composition here for posterity, as I do with other of my rejected stories.
The opulence of the front office door varies inversely with the fundamental solvency of the firm.
